Abstract
Primary cardiac paragangliomas (PCPs) are rare neuroendocrine tumors of the heart. In this issue of the Journal, Chan and colleagues1 share their center's experience in managing patients with PCP, presenting a cohort of 19 patients with a perioperative mortality of 10.6%. The surgical steps are complex yet through experience and wise application of oncologic principles, this center is now a site of established excellence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
